Current Protocols Webinars



The 2018 Wiley Prize in Biomedical Sciences: Elucidating the mechanism of nonsense-mediated messenger RNA decay
April 13, 2018

  • Lynne E. Maquat - Ph.D., Professor, University of Rochester Medical Center

Click here to be notified of future Current Protocols webinars

Available On Demand

Current Protocols webinars are available for viewing approximately 2 days after the live event. If you did not pre-register, a very brief, free registration is required. Slides from each presentation are also available for downloading.

The Complex Pharmacology of T-Cell CARs
Tuesday, December 12, 2017 and Wednesday, December 13, 2017

  • Charles Pussak, Ph.D. - Director of the Cell Therapy Translational Laboratory at UCSD

Generation and Use of iPSC-derived Microglia to Study Neurodegenerative Diseases
Tuesday, December 5, 2017

  • Mathew Blurton-Jones, Ph.D. - University of California, Irvine

Less is More: Using microCT to Assess Bone Loss in Preclinical Models
Friday, September 29, 2017

  • Alexandra De Lille, Ph.D. Director of Technical Applications for in vivo Imaging at PerkinElmer

The 2017 Wiley Prize in Biomedical Sciences: Cryo-Electron Microscopy
Friday, April 7, 2017

  • Joachim Frank, Ph.D. Columbia University
  • Richard Henderson, Ph.D. MRC Laboratory of Molecular Biology (Cambridge, UK)
  • Marin van Heel, Ph.D. National Nanotechnology Laboratory - LNNano/CNPEM (Campinas, Brazil)

Extracellular Vesicle Detection: Problems, Pitfalls and Solutions
Tuesday, January 31, 2017

  • John Tigges Beth Israel Deaconess Medical Center
  • Vasilis Toxavidis Beth Israel Deaconess Medical Center

Atypical Femur Fractures: Addressing the Problem from a Patient-Centered Perspective
Wednesday, January 18, 2017

  • Sundeep Khosla, Ph.D. Mayo Clinic
  • Deborah Gold, Ph.D. Duke University Medical Center
  • Malachi Mckenna, Ph.D. University Hospital and University College, Dublin
  • Elizabeth Shane, Ph.D. Columbia University

Methods for Validating a Gene Editing Approach to Treating Brain Disease with Zinc Fingers, TALEs, and CRISPR/Cas9
Wednesday, November 9, 2016

  • David Segal, Ph.D. UC-Davis Genome Center
  • Jun Park, Ph.D. MilliporeSigma

Plant Genome Editing and Engineering
Sponsored by Current Protocols in Plant Biology
Thursday, September 15, 2016

  • James Birchler, Ph.D. University of Missouri
  • Dan Voytas, Ph.D. University of Minnesota

Choosing Labels and Conjugating Antibodies for Multicolor Flow Cytometry and Other Immunoassays
Tuesday, June 21, 2016

  • Timothy Bushnell, Ph.D., University of Rochester Medical Center
  • Amedeo Cappione III, Ph.D., MilliporeSigma

Cancer Stem Cells and Mechanisms of Multi-Drug Resistance by Flow Cytometry
Tuesday, June 7, 2016 and Wednesday, June 8, 2016

  • Jordi Petriz, Ph.D., The Jose Carreras Leukemia Research Institute in Barcelona

Serum Alternatives for Adult Stem Cell Expansion for Allogeneic and Autologous Therapies
Wednesday, May 18, 2016

  • Allan Dietz, Ph.D., Scientific Director of the Human Cell Therapy Laboratory at the Mayo Clinic (Rochester, MN)
  • Julie Murrell, Ph.D., Head of Cell Therapy Bioprocessing at MilliporeSigma

The 2016 Wiley Prize in Biomedical Sciences: Autophagy
April 8, 2016

  • Yoshinori Ohsumi, Ph.D., Professor Emeritus, National Institute for Basic Biology, Graduate University for Advanced Studies and Honorary Professor at Tokyo Institute of Technology

Cancer Stem Cells, Hypoxia and Tumor Treatment Response
January 21, 2016

  • Dr. Richard Hill, Ontario Cancer Institute and the University of Toronto

The Race Is On: Faster Turnaround Times in the Diagnosis of Multidrug-Resistant Tuberculosis
December 10, 2015

  • Dr. Max Salfinger, National Jewish Health

Increasing Large-Scale Protein Production Using a Novel Supplement Without Affecting Metabolic Profiles*
November 3, 2015

  • Dr. Adam Elhofy, CSO Essential Pharmaceuticals

The ABCs of ADC (Antibody Drug Conjugate) Characterization*
Wednesday, September 23, 2015

  • Dr. April Xu, Pfizer Biopharmaceutical Science

Simplified Methods for Investigating Deregulation of the Cell Cycle and Apoptosis in Cancer Progression, and the Implications for Anti-Cancer Therapies*
June 23, 2015

  • Dr. Kai Stober, Shionogi Ltd
  • Dr. Kamala Tyagarajan, EMD-Millipore

Overcoming Sample-related Challenges for Elispot and Other Functional T cell Assays To Produce More Reliable Immune Monitoring*
June 10, 2015

  • Sylvia Janetzki, M.D., ZellNet Consulting

Extracellular Vesicle Enrichment and Characterization from Cell Culture Supernatants and Biological Fluids*
May 21, 2015

  • Dr. Aled Clayton, Cardiff University
  • Dr. Amedeo Cappione, III, EMD Millipore

Combining Data-Independent Analysis for Broad-Scale Phenotyping and Targeted Tandem Mass Spectrometry Quantification of Specific Biomarkers*
April 29, 2015

  • Dr. John Koomen, Associate Professor and Scientific Director of Proteomics at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL

The 14th Annual Wiley Prize in Biomedical Sciences Awarded for DNA Damage Response*
April 17, 2015

  • Evelyn Witkin, Ph.D., Professor Emerita, The Waksman Institute of Microbiology at Rutgers, The State University of New Jersey
  • Stephen Elledge, Ph.D., Professor of Genetics at Harvard Medical School

Antimicrobial Stewardship in Hospitals: A Patient Safety Emergency*
January 20, 2015

  • Dr. Dilip Nathwani, Ninewells Hospital and Medical School, Dundee, UK

Q Exactive HF and LipidSearch – The High Performance Solution for Complex Lipidomics*
November 20, 2014

  • Dr. Reiko Kiyonami, Thermo Fisher Scientific
  • Dr. David Peake, Thermo Fisher Scientific

Measuring Toxicity Biomarkers in Mouse Models and Other Small-volume Samples*
November 4, 2014

  • Dr. Mitch McGill, University of Kansas Medical Center
  • Dr. Venkata Sabbisetti, Harvard Medical School

Neuroinflammation Models: Use in Studies of Neurodegeneration and Regeneration*
October 7, 2014

  • Dr. M. Kerry O'Banion, University of Rochester School of Medicine & Dentistry

Multiplexing Mass Spectrometry-Based Identification and Quantification of Site-Specific Reversible Cysteine Modifications*
September 30, 2014

  • Dr. Kay-Hooi Khoo, Academia Sinica, Taiwan

The Role of GC-MS/MS in Metabolomics Experiments and the Exploration of Optimized Workflows*
June 12, 2014

  • Dr. Vladimir Shulaev, Professor in the Dept. of Biological Sciences at the University of North Texas
  • Dwain Cardona, Senior Application Scientist for the Thermo Fisher Scientific GC Triple Quadrupole Mass Spectrometer applications group

Metabolomic Profiling of Anionic Metabolites in Head and Neck Cancer Cells by Capillary Ion Chromatography with Orbitrap Mass Spectrometry*
April 15, 2014

  • Junhua Wang, Thermo Fisher Scientific

  • A Translational Proteomics Workflow Coupling Immunoenrichment to Selected-Reaction Monitoring (MSIA-SRM) and its Application to Alzheimer's Disease*
    December 10, 2013

  • Dr. Mary Lopez, Director of Biomarker Research Initiatives in Mass Spectrometry (BRIMS) at ThermoFisher Scientific

  • Multiplex Assay Design Fundamentals and Applications in Cancer Research*
    October 23, 2013

  • Brian Haab, Head of the Laboratory of Cancer Immunodiagnostics, Van Andel Research Institute
  • Beatriz M. Carreno, Washington University School of Medicine in St. Louis

  • Stem Cell and Reprogramming Research Methods: Practical Considerations for Studies of Disease Including Culture Methods and Genetic Manipulation*
    October 10, 2013

  • Kevin Eggan, HHMI, Harvard Stem Cell Institute

  • Advances in Quantitative Proteomics: Parallel Reaction Monitoring Applied to Large-scale Studies*
    June 26, 2013

  • Prof. Bruno Domon, Leader of Clinical Proteomics, Luxembourg Clinical Proteomics Center at CRP-Santé

  • LC-MS-based Metabolomics: Workflows, Strategies and Challenges*
    June 19, 2013

  • Dr. Clary Clish, Director of the Metabolite Profiling Platform, Broad Institute - MIT, Harvard

  • Flow Cytometry: Essential Instrument and Experimental Design Considerations*
    June 5, 2013

  • Dr. J. Paul Robinson, SVM Professor of Cytomics and Professor of Biomedical Engineering, Purdue
  • Dr. John P. Nolan, International Society for Advancement of Cytometry President

  • Advances in Protein Detection and Quantitation Methods: Learn the Crucial Differences and Limitations*
    May 16, 2013

  • Dr. Paul Wingfield, Director of NIAMS Protein Expression Lab, NIH
  • Nuno Goncalves, Manager of Novel Biomolecular Detection, EMD Millipore

  • Glycan Analysis, An Expert Overview of Glycomics Techniques and Workflow Strategies
    Feb 6, 2013

  • Dr. Lara Mahal, Associate Professor of Chemistry at New York University in the Biomedical Chemistry Institute
  • Dr. Anne Dell, CBE FRS FMedSci, Head of the Glycobiology Training, Research and Infrastructure Centre (GlycoTRIC) at Imperial College London

  • Nanoparticle Fabrication and Characterization for Biomedical Research Applications
    June 26, 2012

  • Dr. Jennifer Grossman, Scientist at the National Cancer Institute’s Nanotechnology Characterization Laboratory
  • Dr. Pascale Leroueil, Scientific Program Manager for the Michigan Nanotechnology Institute for Medicine and Biological Sciences

  • Molecular Diagnostics: Translation from the Bench to the Clinic
    April 21, 2011

  • Dr. Joshua LaBaer, Director of the Piper Center for Personalized Diagnostics at the Biodesign Institute at Arizona State University
  • Dr. Wayne Grody, Director of the Diagnostic Molecular Pathology Laboratory at the UCLA Medical Center

  • Strategies for Producing Membrane Proteins in E. coli vs. Yeast*
    March 16, 2011

  • Dr. James Love, Head of Research for The New York Consortium on Membrane Protein Structure (NYCOMPS)
  • Dr. Mark Dumont, Professor of Biochemistry and Biophysics at the University of Rochester Medical School

  • *FREE registration required to view.